By Assoc. Prof. Dr. Mehmet Sorar | Published: 04.02.2025
Ankara TMS Doctor: A Guide to Finding the Right Specialist in the Capital
When you look for a doctor for transcranial magnetic stimulation (TMS), two questions matter most: is TMS an evidence-supported option for your condition, and who will make that assessment? This guide ranks no doctor or centre, in Ankara or elsewhere. It gives neutral criteria that you can apply to any provider: the referral route, screening, operator training, device and clearance information, and how response will be measured.
Which doctor assesses whether TMS is suitable?
That depends on the service, and the guidance cited here names no single specialty. The Oxford Health NHS Foundation Trust leaflet (2026) describes one service model. That service uses repetitive TMS (rTMS) only for treatment-resistant depression, including bipolar depression, and for anxiety. It works by psychiatrist referral and treats people whose condition has not responded to antidepressants and talking therapy. The first US clearance, in 2008, was likewise for adults with depression who had not responded to antidepressants, according to the 2022 timeline by Cohen and colleagues.
That is one service's model, and other places may organise care differently. This guide does not treat a doctor's years of practice or number of cases as a measure of quality. What you can ask is which field the doctor works in, where they were trained in TMS, and whether the person who decides that TMS is indicated is the same person who operates the coil. If they differ, ask who is responsible for what.
What should a first assessment cover?
A sound first assessment establishes why TMS is being considered, how earlier treatments worked and whether you are suitable. Based on the Cleveland Clinic page and the Oxford leaflet, expect to be asked about:
- The condition and the treatments already tried.
- Epilepsy or any earlier seizure. The Cleveland Clinic says the provider may change medicines or suggest another treatment when the seizure risk is higher.
- Metal or electronic implants in the head or neck, a pacemaker or a defibrillator.
- Alcohol use, sleep and earlier brain injury, which the Oxford leaflet says may raise seizure risk.
- What benefit and what risks are expected, and which evidence they rest on.
An assessment can also end with the conclusion that TMS is not suitable. In that case, you can expect another option to be explained. The screening items are set out in more detail on the page about preparing for TMS sessions.
Which questions can you put to any centre?
The same questions can go to every centre, and written answers make the replies comparable.
| Question | Why it is worth asking |
|---|---|
| Which device is used, and what is it cleared for? | US clearances are given by device and by condition (Cohen and colleagues). US clearances say nothing about how devices are registered in Türkiye, so ask the centre. |
| Is my condition one of the cleared uses? | According to the Cleveland Clinic and Cohen and colleagues, the main US-cleared uses are depression, obsessive-compulsive disorder (OCD), migraine with aura, quitting smoking and depression with anxiety. A request for Alzheimer's disease was denied in 2019. |
| How was the operator trained? | The 2021 expert guideline from the International Federation of Clinical Neurophysiology (IFCN), by Rossi and colleagues, sets minimum training requirements for operators. |
| How and when will my response be measured? | The Cleveland Clinic says only that many people with depression or OCD notice improvement. It gives no percentage. |
| What programme is planned, and why? | The Cleveland Clinic gives a typical schedule of 5 days a week for 4 to 6 weeks, often about 30 to 36 sessions for depression. If the proposed programme differs, ask for the reason. |
| If a success rate is quoted, where does it come from? | The Cleveland Clinic page gives no success rate. Trial figures exist for some conditions, but they describe trial participants, not a centre's results. Ask which study, condition and comparison the figure comes from. |
| What happens if a seizure occurs? | The Cleveland Clinic calls seizure the most serious side effect and very rare. A centre can still be expected to have a plan. |
Which claims deserve a second question?
Claims that do not fit the published evidence are a cue to ask for more detail. Watch for these:
- "FDA approved" with no condition named. Clearance is tied to a condition, and devices are cleared rather than approved.
- TMS offered as a cleared or proven treatment for Alzheimer's disease or Parkinson's disease. The Alzheimer's request was denied in 2019, and the Cleveland Clinic lists Parkinson's disease as under study.
- A CE mark presented as proof of benefit. The manufacturer BrainsWay says the CE mark of its device covers a broad list including Alzheimer's and Parkinson's disease, but its page does not say which evidence supports those uses.
- TMS described as suitable for every condition. The review by Di Passa and colleagues found mixed results for attention deficit hyperactivity disorder, post-traumatic stress disorder (PTSD) and schizophrenia and limited or mixed results for other conditions in deep TMS trials. The Cleveland Clinic lists bipolar disorder, PTSD and schizophrenia as under study.
- A claim of no side effects. The Cleveland Clinic names headache, scalp discomfort and mild facial twitching as common.
- No questions about metal, implants or seizure history before starting.
The conditions that have clearance are laid out in the page on what TMS is, and the Alzheimer's position is on the page about TMS in Alzheimer's disease.
Why does access to the team matter once treatment has begun?
Sessions are spread over weeks, so you need a team you can reach if side effects appear or your health changes. The Oxford leaflet says headache usually settles with simple painkillers and eases as sessions continue. The Di Passa review lists seizures and suicidal thoughts or attempts among the rare serious events in deep TMS studies. Seizure figures are collected on the page about TMS safety data.
Which problems should not wait for the next appointment?
A seizure or loss of consciousness away from the clinic needs emergency help. Contact the team about a worsening headache, a mood change or a new implant or medicine, and do not wait for the next session. Specifically:
- A seizure. Call emergency services if it happens after you have left, and tell the team afterward.
- A headache that simple painkillers do not relieve or that keeps increasing.
- Thoughts of harming yourself or a marked worsening of mood. Seek a doctor or emergency services at once.
- A new metal or electronic implant, or a new medicine started during the course.
Sources
- Oxford Health NHS Foundation Trust: rTMS patient information leaflet (v7.0, 2026)
- Cleveland Clinic: Transcranial Magnetic Stimulation (TMS)
- Cohen et al.: A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices, Brain Stimulation 2022
- Rossi et al.: Safety and recommendations for TMS use in healthy subjects and patient populations (IFCN expert guidelines), Clinical Neurophysiology 2021
- BrainsWay (device manufacturer, commercial source): What Mental Health Conditions Is Deep TMS FDA-Cleared To Treat?
- Di Passa et al.: Clinical efficacy of deep transcranial magnetic stimulation (dTMS) in psychiatric and cognitive disorders: A systematic review, Journal of Psychiatric Research 2024
This article is for general information and does not replace medical diagnosis or treatment. Please consult your physician for advice about your own condition.
Assoc. Prof. Dr. Mehmet Sorar
Neurosurgeon in Ankara. Graduated from Gazi University Faculty of Medicine in 1997, specialist since 2004, associate professor since 2019. Full CV
Related treatment page: TMS Tedavisi